Concerning CRC, persistent STAT3 activation has been linked to enhanced CRC cell proliferation and tumor growth [18] and is correlated with poor prognosis of clinical outcomes for CRC patients [19,20]. Here, STAT3 is linked to colorectal carcinoma.